Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Abbott Laboratories shares valued at $337,116 were sold by Blount Sally E. on Apr 30 ’25. At $129.66 per share, Blount Sally E. sold 2,600 shares. The insider’s holdings dropped to 34,058 shares worth approximately $4.65 million following the completion of this transaction.
Also, SALLY E BLOUNT purchased 2,600 shares, netting a total of over 337,116 in proceeds.
Before that, Earnhardt Lisa D had sold 91,167 shares from its account. In a trade valued at $12,199,968, the EVP AND GROUP PRESIDENT traded Abbott Laboratories shares for $133.82 each. Upon closing the transaction, the insider’s holdings decreased to 91,167 shares, worth approximately $9.81 million.
As published in their initiating research note from Oppenheimer on October 08, 2024, Abbott Laboratories [ABT] has been an Outperform and the price target has been revised to $130. Analysts at Piper Sandler started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid September. As of July 30, 2024, Edward Jones has decreased its “Buy” rating to a “Hold” for ABT. Earlier on May 30, 2024, Goldman initiated its rating. Their recommendation was “a Buy” for ABT stock.
Analyzing ABT Stock Performance
On last trading session,, Abbott Laboratories [NYSE: ABT] rose 0.86% to $136.45. The stock’s lowest price that day was $135.455, but it reached a high of $136.89 in the same session. During the last five days, there has been a surge of approximately 1.87%. Over the course of the year, Abbott Laboratories shares have jumped approximately 20.63%.
Support And Resistance Levels for Abbott Laboratories (ABT)
RSI (Relative Strength Index) is 63.46 on the 14-day chart, showing neutral technical sentiment.
Is Abbott Laboratories subject to short interest?
Stocks of Abbott Laboratories saw a sharp steep in short interest on 2025-05-30 dropping by -1.02 million shares to 20.09 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 21.12 million shares. A decline of -5.09% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.01 of the overall float, the days-to-cover ratio (short ratio) decline to 3.01.
Which companies own the most shares of Abbott Laboratories (ABT)?
In terms of Abbott Laboratories share price expectations, FactSet research, analysts set an average price target of 137.5 in the next 12 months, up nearly 1.64% from the previous closing price of $135.28. Analysts anticipate Abbott Laboratories stock to reach 140 by 2025, with the lowest price target being 135. In spite of this, 13 analysts ranked Abbott Laboratories stock as Buy at the end of 2025.
